PRF Technologies PRFX
NASDAQ PRFX
$0.72 -0.04 (-5.26%)
At close: Oct 22, 2026 · 4:00 PM EDT

PRF Technologies (PRFX) Amortization of Deferred Charges (2020)

Updated

Analysis

PRF Technologies (PRFX) Amortization of Deferred Charges (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 PRF Technologies 453,581.09 -22.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 366,000.00
Jun 30, 2020 259,000.00
Mar 31, 2020 362,000.00
API Access

PRF Technologies Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=PRFX&period=max&api_key=YOUR_API_KEY